COMMUNIQUÉS West-GlobeNewswire

Altimmune Announces Second Quarter 2026 Financial Results and Business Update
12/08/2026
Initiated global PERFORMA Phase 3 trial in MASH Reported positive topline data from RECLAIM Phase 2 trial in AUD Completed patient enrollment in RESTORE Phase 2 trial in ALD $519 million in cash, cash equivalents and [...]
Robotic Technology at Medicana: CyberKnife Tracks Tumors in Real Time and Adjusts Radiation as Patients Breathe
12/08/2026
Medicana Health Group radiation oncologist Prof. Dr. Kaan Oysul says real-time motion tracking helps keep radiation focused on moving tumors while limiting exposure to nearby critical organs Photo: Prof. Dr. Kaan Toysul [...]
Regenix Labs Announces Educational Guide on Cortisol, Stress Management, and Healthy Adrenal Function
12/08/2026
New educational guide explores cortisol, stress management, and nutritional ingredients that support overall wellness and healthy adrenal function. Regenix Labs logo. NEWARK, Del., Aug. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Applied Biologics Launches National Health System Partnership Initiative
12/08/2026
Company expands strategic engagement with health systems, integrated delivery networks, and group purchasing organizations to support physicians and patients nationwide SCOTTSDALE, Ariz., Aug. 12, 2026 (GLOBE NEWSWIRE [...]
Inc. Recognizes U.S. Oral Surgery Management as One of the Fastest-Growing Private Companies in America
12/08/2026
USOSM Earns a Place on the Inc. 5000 List for Revenue Growth IRVING, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- For the second year in a row, U.S. Oral Surgery Management ( USOSM ) has been named to the Inc. 5000 list, an [...]
Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer
12/08/2026
DALLAS, Aug. 12, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has delivered the kind of clinical update that can change the conversation around a small biotechnology company: its Phase 2a study of [...]
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
12/08/2026
WILMETTE, Ill., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with [...]
Conavi Medical Corp. Announces Closing of $10M Public Offering
12/08/2026
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“ Conavi ” or the “ Company ”), a commercial stage [...]
Kyowa Kirin Introduces Family Outreach Initiative to Support Families Living with XLH
12/08/2026
New resources and events help guide meaningful conversations about the hereditary nature of XLH PRINCETON, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd., [...]
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
12/08/2026
Commercial initiative aims to make VMS+ easier for hospitals to evaluate and adopt TORONTO, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”) (TSXV: VPT; OTC: VPTDF), a [...]
LiveWorld Reports Second Quarter 2026 Financial Results
12/08/2026
LiveWorld continues to Increase its AI investment CAMPBELL, Calif. and NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for second quarter 2026. Three [...]
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
12/08/2026
-- New U.S. and international patents complement existing delivery system patents, extending global IP coverage for the FemBloc solution -- ATLANTA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a [...]
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
12/08/2026
Investigational AI-powered multiomic test is being developed for adults ages 50-80 at high risk who are not currently participating in guideline-recommended lung cancer screening BRISBANE, Calif., Aug. 12, 2026 (GLOBE [...]
Olympia Pharmaceuticals Advances Longevity Offerings With Advanced Injectable CoQ10 Formulation
12/08/2026
Formulated in an advanced MCT oil base, the new 20 mg/mL formulation offers healthcare providers an effective, patient-friendly option for mitochondrial and cardiovascular health ORLANDO, Fla., Aug. 12, 2026 (GLOBE [...]
TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
12/08/2026
First patient dosed in Phase 3 ALLOHA-2™ study; topline readout expected mid-2028 Shared positive initial data from Cohort C of Phase 1 ALLOHA™ study, validating internal commercial-ready manufacturing process Cash and [...]
Kamada Announces Planned Transition of Chief Financial Officer
12/08/2026
REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious [...]
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
12/08/2026
Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer’s disease, in late 2026 Two candidates nominated for development in Acumen’s [...]
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
12/08/2026
Finalized SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 in support of accelerated approval pathway; topline data expected in second half of 2027 Initiated SUNRISE-FA 2 with first patient enrolled [...]
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
12/08/2026
– Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with the Food and Drug [...]

Pages